On 4 February the Gabinete Técnico Farmacéutico M. Camps and consultancy Azierta organise the webinar "Vigilance and post-marketing of medical devices".
This training, which will be held online for registered users -attendance is free of charge, subject to registration- will provide an overview of regulation and the steps to be taken to carry out PS monitoring.
The market surveillance and monitoring are an essential part of the marketing of medical devices.This is a sector in continuous innovation and of great importance in the European and Spanish market.
The webinar will be moderated by:
- Mercè Camps. CEO and founder of the Technical Pharmaceutical Cabinet MCamps
- Olegario Cuevas. Healthcare Business Manager at Azierta
The webinar presentation will be conducted by:
- Silvia de Andrés. Medical Devices Officer
- Alberto Orós. Technical Consultant
Surveillance and marketing of medical devices:
webinar programme
-
-
- Introduction
- Surveillance system
- Incident management
- Security corrective actions (FSCA) and security notices (FSN)
- Trend reporting
- Post-market surveillance system
- Periodic Security Update Report (PSUR)
- Post Market Monitoring Report (PMSR)
- Post-marketing clinical follow-up
-
Latest articles in our blog
Children's population studies: assessing safety in children's cosmetics
When a cosmetic product, before being marketed, is first applied to a child population, it is necessary to have previously demonstrated the safety of its use. The question then arises: what studies can be carried out on children to assess their safety?.
New amendment of Annex V to the Cosmetics Regulation
On 6 July, the Official Journal of the European Union (OJEU) published Commission Regulation (EU) 2017/1224 amending Annex V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products. It concerns...
Human tolerance studies What are the necessary requirements?
Human tolerance studies for the cosmetics sector - In our country the necessary requirements are legislated to obtain permission from the health authorities, allowing us to carry out clinical trials to study the effect and efficacy of cosmetic products.